← All companies
Edwards Lifesciences Corp
EW - CIK 0001099800
Market cap$49.51 B
Rank#320
SEC filings2,569
The table below shows Edwards Lifesciences Corp's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.94B | $3.05B | $1.14B | $769.00M | $862.80M | $1.18B |
| Short-term investments | $1.29B | $930.70M | $500.50M | $446.30M | $604.00M | $219.40M |
| Receivables | $659.60M | $609.10M | $775.10M | $643.00M | $582.20M | $514.60M |
| Inventory | $1.13B | $1.09B | $1.17B | $875.50M | $726.70M | $802.30M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.